Several reports indicate that urinary growth hormone (GH) excretion might reflect central release of the hormone, and that measurement of unnary GH shows promise in the investigation of physiological and pathological GH secretion. We have developed and evaluated a direct immunoradiometric assay (IRMA) in which two monoclonal antibodies are used to measure OH in the urine of children. The detection limit is -0.018 pmol/L for a sample volume of 2 mL Within-and between-run variations (CV5) were 5.6% and 14.2%, respectively.Analytical recovery and dilution experiments showed the specificity of the method for OH. In normal-stature prepubertal children ages 3-12 years, 24-h urinary OH excretion was 0.189 (SD 0.100) pmol and correlated well with the amount of GH in the first morning miction, which showed wide day-to-day variations. Like others, we found a strong correlation between OH concentrations in serum and urine during stimulation tests with GH-releasing hormone (somatoliberin) and (or) during physiological nocturnal secretion, confirming that urinary OH measurement may be of help in investigating patients (particularly young children) with diseases in which GH secretion is impaired. 
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Addftlonal Keyphrases:
pediatric chemist r, atoflbi!n Serum growth hormone (GH) concentrations fluctuate greatly in the absence of stimuli (1, 2), and a single blood collection, therefore, provides no useful information on GH secretion.3 Two or more pharmacological tests are required to measure GH secretory capacity and give evidence of a GH secretion deficiency. These Urine was collected for 5 h during the test (the patients were asked to urinate just before the test).
In the sleep test, a catheter was inserted at 2000 h with a slow saline drip. Samples for Gil assay were taken every 20 mm from 2100 to 0630; the children were fully informed as to the nature of the test and slept spontaneously for at least 6 h. We collected morning urine specimens from each child.
We collected urine in polypropylene containers and stored it in 10-mL samples at -20 #{176}C after noting the volume. We thawed the specimens, centrifuged them at 1000 x g to remove particulate material, and used the supernate for the assay.
Data Analysis
The night Gil profiles were analyzed with the PULSAR For our RIA, the assay noise was derived from the equation SD (0.00063x2 + 0.0477x + 0)/100 where x isany given Gil concentration.
The assay SD was calculated from duplicate nocturnal Gil profiles. The smoothing time was set to one-half the total nocturnal profile time. The splitting parameter was set to 2, and the weight assigned to each peak was 0.02.
The following values were extracted from the PULSAR analysis: number of peaks, overall mean, maximal value, mean of the baseline, mean peak height, mean peak amplitude, mean peak area, and mean peak length. The area under the curve was estimated above zero and above the calculated baseline.
Results

Analytical Evaluation
Standard curve, linearity, and detection limit. (Figure 1, top) , and the detection limit was <2 pg/tube (Figure 1, bottom) ; a precision profile amounts (12,23,24) .
The 22500-Da form should therefore represent virtually all the GH in urine. This seems to be confirmed by Albini et al. (10) , who showed that the immunoreactivity of HPLC fractions of urinary Gil was similar in a double-monoclonal IRMA and in a standard Gil polyclonal assay.
In conclusion, the double monoclonal antibody GH assay we propose here appears to be accurate enough to measure urinary Gil. Further clinical studies will be necessary to show its validity in various pathological disorders in which GH secretion can be altered.
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